Department of Hematology, Cancer Hospital of Tianjin, Tianjin Medical University, Tianjin, China.
Cancer Invest. 2011 Jan;29(1):37-41. doi: 10.3109/07357907.2010.496758.
The pathophysiology of multiple myeloma-induced angiogenesis is complex and involves both direct production of angiogenic cytokines by plasma cells and their induction within the microenvironment. In this research, we investigated whether mesenchymal stem cells participated in inducing the angiogenic response in multiple myeloma, and explored the mechanism by which MSCs influence myeloma angiogenesis. We detected the concentration of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium of mesenchymal stem cells and the capillary formation ability of mesenchymal stem cells in vitro. We found that conditioned medium of MSCs derived from MM significantly promoted the proliferation, chemotaxis, and capillary formation of human umbilical vein endothelial cells compared with that from normal donors. ELISA and RT-PCR were used to detect the mRNA and protein levels of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium. We found that mRNA and protein levels of angiogenic factors were elevated in MSCs from multiple myeloma compared with normal donors.
多发性骨髓瘤诱导血管生成的病理生理学较为复杂,既涉及浆细胞直接产生血管生成细胞因子,也涉及在微环境中诱导其产生。在这项研究中,我们研究了间充质干细胞是否参与诱导多发性骨髓瘤中的血管生成反应,并探讨了 MSCs 影响骨髓瘤血管生成的机制。我们检测了间充质干细胞条件培养基中的血管生成因子(bFGF、HGF 和 VEGF)浓度,以及间充质干细胞在体外的毛细血管形成能力。结果发现,与正常供体来源的 MSC 相比,MM 来源的 MSC 条件培养基明显促进了人脐静脉内皮细胞的增殖、趋化和毛细血管形成。ELISA 和 RT-PCR 用于检测条件培养基中血管生成因子(bFGF、HGF 和 VEGF)的 mRNA 和蛋白水平。结果发现,与正常供体相比,多发性骨髓瘤来源的 MSC 中血管生成因子的 mRNA 和蛋白水平升高。